Acutus Medical downgraded by JP Morgan
$AFIB
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
JP Morgan downgraded Acutus Medical from Neutral to Underweight
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
1/20/2022 | Buy → Neutral | BTIG | |
1/14/2022 | $10.00 → $3.00 | Buy → Hold | Canaccord Genuity |
11/15/2021 | Neutral → Underweight | JP Morgan | |
11/12/2021 | Neutral → Underweight | JP Morgan | |
11/12/2021 | $18.00 → $10.00 | Buy | Canaccord Genuity |
10/22/2021 | $10.00 | Neutral | Goldman |
7/15/2021 | $11.00 → $18.00 | Hold → Buy | Canaccord Genuity |